Janhavi Nimbalkar

Can pharmacogenomics transform personalized medicine into routine clinical practice? Current evidence and future directions

Personalized medicine (PM) represents a transformative approach in healthcare, particularly in oncology, by tailoring treatments to individual genetic, molecular, and clinical profiles, thereby improving therapeutic specificity and minimizing adverse effects. A key component of this approach is pharmacogenomics (PGx),...

Plant-derived phytochemicals for Alzheimer's disease: mechanisms of action, experimental evidence, and therapeutic perspectives.